左甲状腺素处方的适当性:一项多中心回顾性研究
该多中心回顾性研究纳入2017至2020年间在美国三个学术中心首次接受左甲状腺素处方的成人患者977例,将处方分为适当、不确定和无证据支持三类,发现54%的处方无证据支持,最常见的无证据支持原因为初始促甲状腺激素低于10 mIU/L且无既往甲状腺功能检测结果。
要点
- 近半数左甲状腺素处方无证据支持(528/977,54%)。
- 无证据支持处方最常见原因为初始促甲状腺激素低于10 mIU/L且无既往检测(131/528,25%)。
- 女性及由基层医疗提供者开具处方与无证据支持处方相关。
核心结论
- 无证据支持的左甲状腺素处方占相当比例,作者认为需进一步研究以重复这些发现并探讨处方者与接受者的观点。
研究设计与样本
- 回顾性多中心研究,纳入2017至2020年间在美国三个学术中心首次接受左甲状腺素处方的成人患者977例。
主要发现
- 无证据支持处方528例(54%),适当处方307例(31%),不确定处方118例(12%)。
- 无证据支持处方最常见原因为初始促甲状腺激素低于10 mIU/L且无既往促甲状腺激素或甲状腺素检测值(131/528,25%)。
- 适当处方最常见原因为明显甲状腺功能减退症(163/307,53%)。
- 不确定处方最常见原因为未确认的亚临床甲状腺功能减退症且促甲状腺激素大于等于10 mIU/L(无确认检测)(51/118,43%)。
- 多变量分析中,女性(OR 1.3;95% CI 1.0-1.7)和由基层医疗提供者开具处方(OR 1.5;95% CI 1.2-2.0)与无证据支持处方相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Levothyroxine is one of the most prescribed medications in the United States. OBJECTIVE: This study explores the appropriateness of levothyroxine prescriptions. METHODS: A retrospective multicenter study was conducted on adult patients who were prescribed levothyroxine for the first time between 2017 and 2020 at three academic centers in the United States. We classified each case of levothyroxine initiation into one of three mutually exclusive categories: appropriate (clinically supported), indeterminate (clinically unclear), or nonevidence based (NEB, not clinically supported). RESULTS: A total of 977 participants were included. The mean age was 55 years (SD 19), there was female (69%) and White race predominance (84%), and 44% had possible hypothyroid symptoms. Nearly half of the levothyroxine prescriptions were considered NEB (528, 54%), followed by appropriate (307, 31%) and indeterminate (118, 12%). The most common reason for NEB prescription was an index thyrotropin (TSH) value of less than 10 mIU/L without previous TSH or thyroxine values (131/528, 25%), for appropriate prescription, was overt hypothyroidism (163/307, 53%), and for an indeterminate prescription was a nonconfirmed subclinical hypothyroidism with TSH greater than or equal to 10 mIU/L (no confirmatory testing) (51/118, 43%). In multivariable analysis, being female (odds ratio [OR]: 1.3; 95% CI, 1.0-1.7) and prescription by a primary care provider (OR: 1.5; 95% CI, 1.2-2.0) were associated with NEB prescriptions. CONCLUSION: There is a considerable proportion of NEB levothyroxine prescriptions. These results call for additional research to replicate these findings and to explore the perspective of those prescribing and receiving levothyroxine.
引用
- Ayala IN, Soto Jacome C, Toro-Tobon D, et al. Appropriateness of Levothyroxine Prescription: A Multicenter Retrospective Study. J Clin Endocrinol Metab. 2024. PMID: 37656124. doi:10.1210/clinem/dgad517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。